Biotech entity
Every one of those 1 sits in a single category, ipo. Of the tracked stories, 1 of 1 also mention Gaudium IVF, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Gaudium IVF and Women Health, all published on February 24, 2026.
Last mentioned: Feb 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, ipo. Of the tracked stories, 1 of 1 also mention Gaudium IVF, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Gaudium IVF and Women Health, all published on February 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Gaudium IVF and Women Health. Shared-story counts are live from our verified record — not editorial picks.
Final Bidding Day
The bidding process concludes with a 6.33% GMP trend.
Day 2 Milestone
Subscription reaches 3x overall with strong retail participation.
IPO Opens
Gaudium IVF opens its initial public offering for subscription.
Gaudium IVF and Women Health has reached its final day of bidding with an overall subscription of three times as of the end of Day 2. The offering is seeing strong retail interest and maintains a 6.33% grey market premium, signaling a positive market debut.
Gaudium IVF and Women Health is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
